Eagle Clinical Tresos PRO Neurocrine

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

tyrosine, Quantity: 100 mg; ornithine monohydrochloride, Quantity: 255.07 mg (Equivalent: ornithine, Qty 200 mg); calcium pantothenate, Quantity: 75 mg (Equivalent: pantothenic acid, Qty 68.71 mg; Equivalent: calcium, Qty 6.29 mg); pyridoxal 5-phosphate monohydrate, Quantity: 25 mg (Equivalent: pyridoxine, Qty 15.95 mg); soy phosphatidylserine-enriched soy lecithin powder, Quantity: 141.43 mg (Equivalent: soy phosphatidylserine, Qty 100 mg)

から入手可能:

Integria Healthcare Australia Pty Ltd

医薬品形態:

Tablet, film coated

構図:

Excipient Ingredients: colloidal anhydrous silica; crospovidone; chlorophyllin-copper complex; calcium hydrogen phosphate dihydrate; macrogol 400; microcrystalline cellulose; povidone; silicon dioxide; croscarmellose sodium; iron oxide black; hypromellose; Carnauba Wax; magnesium stearate

投与経路:

Oral

適応症:

Helps convert (state food) into energy ; Maintain/support energy production ; Maintain/support general health and wellbeing ; Aid/assist healthy red blood cell production ; Maintain/support red blood cell health ; Maintain/support healthy thyroid gland function ; Maintain/support healthy thyroid hormones ; Maintain/support thyroid gland health ; Aid/assist thyroid hormone production ; Aid/assist/helps glucose/sugar/carbohydrate metabolism ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Maintain/support (state vitamin/mineral) within normal range ; Support healthy stress response in the body ; Maintain/support neuroendocrine function ; Aid/assist/helps synthesis of neurotransmitters ; Support healthy emotional/mood balance

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2022-09-29